EFFICIENCY OF COMPLEX REHABILITATION PROGRAM IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT

被引：0
|
作者：
Orlova, E. [1 ]
Karateev, D. [2 ]
Kochetkov, A. [1 ]
机构：
[1] Fed Med Biol Agcy, Dept Rehabil Med, Moscow, Russia
[2] Moscow Reg Res & Clin Inst MONIKI, Dept Internal Med 1, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6278
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0684
引用
收藏
页码：861 / 861
页数：1
相关论文
共 50 条
  • [21] Antibody Response To Pneumococcal and Influenza Vaccination In Patients With Rheumatoid Arthritis Receiving Subcutaneous Abatacept.
    Genovese, M. C.
    Bingham, C. O., III
    Cohen, S.
    Calabrese, L.
    Curtis, J. R.
    Block, A.
    Fay, J.
    Kelly, S.
    Luo, A.
    Wong, D.
    Alten, R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S198 - S198
  • [22] Eruptive squamous cell carcinoma in a patient receiving abatacept for rheumatoid arthritis
    Corcorran, Maria A.
    Olson, Jonathan M.
    Hecht, Corinne
    Knezevich, Stevan
    Vary, Jay C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (04) : E178 - E179
  • [23] Complex measures for the rehabilitation in rheumatoid arthritis
    Krohn-Grimberghe, B
    Kurzeja, R
    AKTUELLE RHEUMATOLOGIE, 2004, 29 (05) : 255 - 263
  • [24] The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis
    Sandoo, A.
    Kitas, G. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : 589 - 589
  • [25] THE INFLUENCE OF ABATACEPT ON BIOMARKERS LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Borisova, M. B.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Luchihina, E. L.
    Karateev, D. E.
    Alexandrova, E. N.
    Novikov, A. A.
    Cherkasova, M.
    Glukhova, S. I.
    Nasonov, E. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S73 - S74
  • [26] THE EFFECT OF ABATACEPT ON CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Borisova, M. A.
    Lukina, G. V.
    Sigidin, Y.
    Luchihina, E. L.
    Karateev, D. E.
    Novikov, A.
    Alexandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 576 - 576
  • [27] Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy
    Chen, Yi-Ming
    Huang, Wen-Nan
    Liao, Tsai-Ling
    Chen, Jun-Pen
    Yang, Sheng-Shun
    Chen, Hsin-Hua
    Hsieh, Tsu-Yi
    Hung, Wei-Ting
    Chen, Yi-Hsing
    Chen, Der-Yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) : 849 - +
  • [28] Rehabilitation of Patients with Rheumatoid Arthritis
    Kerschan-Schindl, K.
    Machold, K.
    PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN, 2011, 21 (06) : 297 - 308
  • [29] Characteristics of Rheumatoid Arthritis Patients Initiating Abatacept Therapy
    Thyagarajan, Veena
    Simon, Teresa A.
    Liu, Nan
    Lin, Nancy D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 470 - 471
  • [30] Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
    Takahashi, Nobunori
    Kojima, Toshihisa
    Terabe, Kenya
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Fukaya, Naoki
    Ishikawa, Hisato
    Hayashi, Masatoshi
    Tsuboi, Seiji
    Kato, Daizo
    Funahashi, Koji
    Matsubara, Hiroyuki
    Hattori, Yosuke
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Yoshioka, Yutaka
    Ishiguro, Naoki
    MODERN RHEUMATOLOGY, 2013, 23 (05) : 904 - 912
12345